Advertisement
Canada markets open in 6 hours 23 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7329
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    83.96
    +0.39 (+0.47%)
     

  • Bitcoin CAD

    87,810.19
    +97.84 (+0.11%)
     

  • CMC Crypto 200

    1,391.06
    -5.48 (-0.39%)
     

  • GOLD FUTURES

    2,352.90
    +10.40 (+0.44%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,773.75
    +206.25 (+1.17%)
     

  • VOLATILITY

    15.37
    0.00 (0.00%)
     

  • FTSE

    8,078.86
    0.00 (0.00%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

Eidos Therapeutics (EIDX) Looks Good: Stock Adds 6.4% in Session

Zacks Equity Research
·2 min read

Eidos Therapeutics, Inc. EIDX was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $43.70 –$52.64 in the past one-month time frame, witnessed a sharp increase yesterday.

The company's Zacks Consensus Estimate for the current quarter has moved higher over the past few weeks, suggesting that more solid trading could be ahead for Eidos Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Eidos Therapeutics currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Eidos Therapeutics, Inc. Price

Eidos Therapeutics, Inc. Price
Eidos Therapeutics, Inc. Price

Eidos Therapeutics, Inc. price | Eidos Therapeutics, Inc. Quote

ADVERTISEMENT

A better-ranked stock in the Medical - Biomedical and Genetics industry is Emergent Biosolutions Inc. EBS, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Emergent Biosolutions Inc. (EBS) : Free Stock Analysis Report
 
Eidos Therapeutics, Inc. (EIDX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research